...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Receives Approval From The FDA Cardiovascular and Renal Division To Proceed With A Requested Apabetalone Clinical Trial

This is great news in my opinion.

The scientific interest, credibility and trust continues to build momentum.

The money will flow without question IMHO.

Toinv

Share
New Message
Please login to post a reply